Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HQ Sustainable Maritime Industries was an integrated aquatic product company that specialized in the production, processing, and marketing of tilapia and various health products derived from aquatic sources. Based primarily in Hainan, China, the company developed a range of nutraceuticals and functional foods, including collagen peptides and Omega-3 fatty acids extracted from fish processing byproducts. Its business model aimed to leverage sustainable aquaculture to provide high-quality protein and health supplements to both domestic Chinese and international markets. However, the company faced significant legal and financial turmoil, leading to its delisting from the NYSE Amex in 2011 following allegations of financial irregularities and fraud.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HQ Sustainable Maritime Industries.